Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2483-2025

3M Ranger Blood/Fluid Warming High Flow Set Catalog Numbers 24355, 24370 Recall

3M Ranger Blood/Fluid Warming High Flow Set Catalog Numbers 24355, 24370

FDA recall Class I

Ongoing

FDA lists this Class I recall for 3M Ranger Blood/Fluid Warming High Flow Set Catalog Numbers 24355, 24370. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2483-2025
Recall classification
Class I
Enforcement status
Ongoing
Initiation date
Apr 10, 2025
FDA report date
Sep 24, 2025
Quantity in commerce
530,470 units
Distribution
See key details
FDA cause
Device Design

What is being recalled?

3M Ranger Blood/Fluid Warming High Flow Set Catalog Numbers 24355, 24370

Affected model & UDI checker

Search the exact identifiers published for Z-2483-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
243553M Ranger Blood/Fluid Warming High Flow Set Catalog Numbers 24355, 24370Check source noticeNot specified
FDA code information

All lots with a manufacturing date after March 2022.

View the original FDA recall notice

Why was this product recalled?

Field action to clarify the flow rates and inlet fluid temperatures, along with location of the outlet temperature for Ranger Blood/Fluid Warming High Flow Sets.

What actions did 3M COMPANY take?

An Urgent Medical Device Correction letter was sent to all their customers on 4/21/2025 to inform them that Solventum [formerly 3M Company] clarified flow rates related to the inlet fluid temperature. The device instructions for use (IFU) will be updated to reflect these changes. Customers are informed that there have been no changes to the design or composition of these products that prompted this notification. Customers are instructed to continue to use the products as indicated, considering the updated information provided in the letter. If the device is used at a flow rate outside of the updated information provided, there is a potential risk for the device to administer the fluids at a lower temperature than indicated and cause a decrease in patient temperature. Under the dire circumstances of a massive rapid infusion where high flow rates outside of the updated ranges indicated below may be used, there is a potential for hypothermia. Customers with additional questions or need to report an adverse event, are instructed to contact the Solventum [formerly 3M Health Care] Customer Helpline at 1-800-228-3957, option 6.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology